WallStreetZenWallStreetZen

NASDAQ: VIGL
Vigil Neuroscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VIGL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$83.8M
Current Profit Margin
0%

VIGL Return on Equity

Current Company
-76%
Current Industry
22.9%
Current Market
33.8%
VIGL's Return on Equity (-76%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VIGL announces earnings.

VIGL Return on Assets

Current Company
-62.9%
Current Industry
3.5%
VIGL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VIGL Return on Capital Employed

Current Company
-85.8%
Current Industry
21.4%

VIGL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VIGL$0.00-$82.01M-$83.84MN/AN/A
VTYX$0.00-$169.91M-$171.30MN/AN/A
ABOS$0.00-$62.11M-$64.86MN/AN/A
ACHV$0.00-$24.13M-$27.54MN/AN/A
ADVM$0.00-$89.39M-$99.86M-100.00%N/A
View Top Biotech Stocks

Vigil Neuroscience Earnings & Revenue FAQ

What were VIGL's earnings last quarter?

Vigil Neuroscience (NASDAQ: VIGL) reported Q2 2024 earnings per share (EPS) of -$0.52, up 0% year over year. Total Vigil Neuroscience earnings for the quarter were -$21.23 million. In the same quarter last year, Vigil Neuroscience's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Vigil Neuroscience stock.

What was VIGL's earnings growth in the past year?

As of Q3 2024, Vigil Neuroscience's earnings has grown year over year. Vigil Neuroscience's earnings in the past year totalled -$83.84 million.

What was VIGL's revenue last quarter?

Vigil Neuroscience (NASDAQ: VIGL) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Vigil Neuroscience's revenue was $0.00.

What was VIGL's revenue growth in the past year?

As of Q3 2024, Vigil Neuroscience's revenue has grown null year over year. Vigil Neuroscience's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.